Skip to content

MEDICINOVA, INC.: 10-Q filed 2021-11-12

What MEDICINOVA, INC. reported in its quarterly report filed 2021-11-12 (fiscal Q3 2021): 33 published measures, 89 facts as tagged in accession 0001564590-21-056378.

This filing

Form
10-Q (quarterly report)
Filed
2021-11-12
Fiscal period
fiscal Q3 2021
Accession
0001564590-21-056378 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MEDICINOVA, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-09-3091,623,960USD
At 2020-12-3175,419,110USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-09-305,141,620USD
At 2020-12-314,092,610USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-09-3086,482,340USD
At 2021-06-3089,234,314USD
At 2021-03-3192,371,449USD
At 2020-12-3171,326,500USD
At 2020-09-3073,553,273USD
At 2020-06-3071,092,943USD
At 2020-03-3173,196,268USD
At 2019-12-3174,894,623USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-09-3075,025,384USD
At 2020-12-3160,036,763USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-3,579,167USD92
2021-01-01 to 2021-09-30-8,051,107USD273
2021-04-01 to 2021-06-30-4,284,141USD91
2021-01-01 to 2021-03-31-187,799USD90
2020-07-01 to 2020-09-30-3,703,820USD92
2020-01-01 to 2020-09-30-10,868,608USD274
2020-04-01 to 2020-06-30-4,451,229USD91
2020-01-01 to 2020-03-31-2,713,559USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-5,742,639USD273
2020-01-01 to 2020-09-30-8,877,277USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2021-01-01 to 2021-09-3028,732USD273
2020-01-01 to 2020-09-303,794USD274

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2021-07-01 to 2021-09-3037,500USD92
2021-01-01 to 2021-09-304,037,500USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-09-3020,739,282USD273
2020-01-01 to 2020-09-306,747,109USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-28,732USD273
2020-01-01 to 2020-09-30-3,794USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-09-30-390,977,949USD
At 2020-12-31-382,926,842USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-09-3064,317USD
At 2020-12-3155,700USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2021-01-01 to 2021-09-302,474,485USD273
2020-01-01 to 2020-09-302,777,503USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-3,601,939USD92
2021-01-01 to 2021-09-30-8,112,981USD273
2020-07-01 to 2020-09-30-3,730,016USD92
2020-01-01 to 2020-09-30-11,164,881USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-09-3076,160,111USD
At 2020-12-3160,716,934USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-09-304,202,112USD
At 2020-12-312,193,950USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-09-30642,418USD
At 2020-12-31616,629USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2021-09-309,600,240USD
At 2020-12-319,600,240USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-07-01 to 2021-09-303,639,439USD92
2021-01-01 to 2021-09-3012,150,481USD273
2020-07-01 to 2020-09-303,730,016USD92
2020-01-01 to 2020-09-3011,164,881USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2021-07-01 to 2021-09-302,000,000USD92
2021-01-01 to 2021-09-306,400,000USD273
2020-07-01 to 2020-09-302,100,000USD92
2020-01-01 to 2020-09-305,400,000USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-09-3049,028,246shares
At 2020-12-3145,024,560shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2021-09-30-95,039USD
At 2020-12-31-88,219USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2021-09-30881,754USD
At 2020-12-31170,857USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2021-09-30888,398USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2021-09-30117,538USD
At 2020-12-3175,379USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2021-09-30737,716USD
At 2020-12-312,705USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2021-09-301,134,727USD
At 2020-12-31680,171USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

PeriodValueUnitDays
At 2021-09-30201,792USD
At 2020-12-31201,792USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-8,051,107USD273
2020-01-01 to 2020-09-30-10,868,608USD274

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-3,580,529USD92
2021-01-01 to 2021-09-30-8,057,927USD273
2020-07-01 to 2020-09-30-3,701,059USD92
2020-01-01 to 2020-09-30-10,865,962USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-301,550,821USD92
2021-01-01 to 2021-09-305,389,466USD273
2020-07-01 to 2020-09-301,492,139USD92
2020-01-01 to 2020-09-305,477,223USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2021-01-01 to 2021-09-3019,775USD273
2020-01-01 to 2020-09-3015,487USD274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-13,381USD92
2021-01-01 to 2021-09-30-45,285USD273
2020-07-01 to 2020-09-30-11,008USD92
2020-01-01 to 2020-09-30-27,902USD274

Inspect the source

Entity
MEDICINOVA, INC. / CIK 0001226616
Captured
2026-09-20T07:46:14.294Z
SEC response SHA-256
2ee4e761c5c78942e5c8408ca3fc8acae481ff5fcfadf88ffba53700bd842714

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001226616.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))